Adial Pharmaceuticals Cash from Financing (TTM) Analysis

Adial Pharmaceuticals Inc (ADIL)

1.70 -0.20 (-10.53%) USD | NASDAQ | Apr 23, 16:00

1.70 0.00 (0.00%) After-Hours: 19:31

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	4.132M
September 30, 2023	0.7483M
June 30, 2023	0.6097M
March 31, 2023	0.6115M
December 31, 2022	9.126M
September 30, 2022	10.38M
June 30, 2022	15.88M
March 31, 2022	18.69M
December 31, 2021	13.64M
September 30, 2021	12.39M
June 30, 2021	7.840M
March 31, 2021	9.688M
December 31, 2020	5.607M

Date	Value
September 30, 2020	5.607M
June 30, 2020	4.658M
March 31, 2020	0.0003M
December 31, 2019	9.247M
September 30, 2019	9.403M
June 30, 2019	15.06M
March 31, 2019	15.35M
December 31, 2018	6.349M
September 30, 2018	6.293M
June 30, 2018	0.675M
March 31, 2018	0.64M
December 31, 2017	0.39M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.0003M

Minimum

Mar 2020

18.69M

Maximum

Mar 2022

8.069M

Average

9.126M

Median

Dec 2022

Cash from Financing (TTM) Benchmarks